Magnesium Glycinate Sleep Latency Meta-analysis: What the Evidence Says

Quick Answer

Magnesium Glycinate Sleep Latency Meta-analysis has 2 source documents in the current Migaku evidence database. The strongest available sources in this first pass are mixed biomedical and public-health sources, so conclusions should be framed as evidence-aware guidance rather than medical advice.

Key Takeaways

• This page is generated only from sources stored in the Migaku evidence knowledge base.
• Current evidence mix: 1 narrative review, 1 research article.
• Claims should be interpreted with the source type, study design, population, and publication date in mind.
• This article is educational and does not replace care from a qualified clinician.

Evidence Map

What The Sources Report

• Small sample size Short duration High Insomnia 11 Tunc et al 2023 938 279/659 81.1 / R ISI, ESS Elderly outpatient patients / / Hypomagnesemia is Associated with EDS Unknown if EDS leads to hypomagnesemia or vice versa. [He Caijun (2025); evidence level 3]
• Low levels were associated with a higher CRP concentration in patients with OSA. [He Caijun (2025); evidence level 3]
• Despite its significance, standard serum magnesium testing is unreliable; patients may have normal serum levels of 0.75-0.95 mmol/L yet present with evidence of chronic, underlying deficiency. [Ahmed Sibtain (2026); evidence level 4]
• Evidence suggests that up to 42% of young adults exhibit undetected insufficiency and nearly half of the US population fails to meet the RDA of 300-400 mg/day. [Ahmed Sibtain (2026); evidence level 4]

How To Read This Evidence

Evidence level 1 generally reflects systematic reviews or meta-analyses. Level 2 includes randomized trials, guidelines, or public-health guidance. Level 3 usually reflects observational or narrative-review evidence. Level 4 is weaker or early-stage evidence. The level is a sorting aid, not a final quality grade.

Practical Interpretation

For magnesium glycinate sleep latency meta-analysis, the current source set is useful for orientation, but it is not yet broad enough for strong claims. Use cautious language and keep conclusions close to the cited sources.

Limits Of This First Pass

This is a small-batch MVP article. It uses the first ingested sources for this topic and should be expanded with more targeted searches, license review, and human editorial checks before being treated as a definitive review.

References

• He Caijun (2025). The Mechanisms of Magnesium in Sleep Disorders. DOI: 10.2147/NSS.S552646. PMCID: PMC12535714. PMID: 41116797. License: https://creativecommons.org/licenses/by-nc/4.0/ https://www.dovepress.com/terms.php http://creativecommons.org/licens.... https://pmc.ncbi.nlm.nih.gov/articles/PMC12535714/
• Ahmed Sibtain (2026). Magnesium - The Silent Partner or the Next Vitamin D? Shifting Paradigm in Mineral Metabolism in Health and Disease. PMCID: PMC12882071. PMID: 41659294. License: https://creativecommons.org/licenses/by-nc/4.0/. https://pmc.ncbi.nlm.nih.gov/articles/PMC12882071/

Safety Note

Health information can change, and individual risk depends on medical history, medications, pregnancy status, age, and diagnosis. Talk with a qualified clinician before changing treatment, supplement, or medication routines.